Clinical Trial: Two Trials to Evaluate TEV-53408 in Participants With Non-Segmental Vitiligo

U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07920211) titled 'Two Trials to Evaluate TEV-53408 in Participants With Non-Segmental Vitiligo' on Oct. 30.

Brief Summary: The goal of these clinical trials is to learn if TEV-53408 can help adults with Non-Segmental Vitiligo (NSV). Vitiligo causes patches of skin to lose their color.

The main questions the trials aim to answer are:

Can TEV-53408 help bring color back to the skin on the face? Can TEV-53408 help bring color back to the skin on the body? What side effects may happen with TEV-53408?

TEV-53408 will be compared with placebo to see if it helps bring color back to the skin.

Participants will:

Receive TEV-53408 or placebo as an injection...